CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 8-K Event Material agreement · Other events
- 4 Open-market buy Director bought 105,500 shares at an average $8.55 ($901,702)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale SVP & CFO sold 9,219 shares at $5.57 ($51,350)
- 4 Planned sale SVP & General Counsel sold 5,904 shares at $5.57 ($32,885)
- 4 Planned sale SVP & Chief Compliance Officer sold 2,559 shares at $5.57 ($14,254)
- 4 Option exercise SVP & CFO acquired 31,000 shares (option exercise)
- 4 Option exercise SVP & General Counsel acquired 19,850 shares (option exercise)
- 4 Option exercise SVP & Chief Compliance Officer acquired 8,600 shares (option exercise)
- 8-K Event Material agreement
- 4 Planned sale SVP & CFO sold 13,753 shares at $5.84 ($80,318)
- 4 Planned sale SVP & General Counsel sold 11,308 shares at $5.84 ($66,039)
- 4 Planned sale SVP & Chief Compliance Officer sold 8,759 shares at $5.84 ($51,153)
- 4 Option exercise Director acquired 386 shares (option exercise)
- 4 Option exercise Director acquired 1,814 shares (option exercise)
- 4 Option exercise Director acquired 965 shares (option exercise)
- 4 Option exercise SVP & CFO acquired 42,202 shares (option exercise)
Page 7 of 24 · 463 filings